<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Ophthalmology</journal-id><journal-id journal-id-type="iso-abbrev">Ophthalmology</journal-id><journal-title-group><journal-title>Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0161-6420</issn><issn pub-type="epub">1549-4713</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28438414</article-id><article-id pub-id-type="pmc">5540045</article-id><article-id pub-id-type="publisher-id">S0161-6420(17)30262-2</article-id><article-id pub-id-type="doi">10.1016/j.ophtha.2017.03.016</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Predictors of Trachomatous Trichiasis Surgery Outcome</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Habtamu</surname><given-names>Esmael</given-names></name><degrees>MSc</degrees><email>Esmael.Ali@lshtm.ac.uk</email><xref rid="aff1" ref-type="aff">1</xref><xref rid="aff2" ref-type="aff">2</xref><xref rid="cor1" ref-type="corresp">&#x02217;</xref></contrib><contrib contrib-type="author"><name><surname>Wondie</surname><given-names>Tariku</given-names></name><degrees>BA</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Aweke</surname><given-names>Sintayehu</given-names></name><degrees>MPH</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Tadesse</surname><given-names>Zerihun</given-names></name><degrees>MD, MPH</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Zerihun</surname><given-names>Mulat</given-names></name><degrees>MPH</degrees><xref rid="aff2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Gashaw</surname><given-names>Bizuayehu</given-names></name><degrees>MHA</degrees><xref rid="aff3" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><name><surname>Wondimagegn</surname><given-names>Guadie S.</given-names></name><degrees>MD, M.med</degrees><xref rid="aff4" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><name><surname>Mengistie</surname><given-names>Hiwot D.</given-names></name><degrees>MD, M.med</degrees><xref rid="aff5" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Rajak</surname><given-names>Saul N.</given-names></name><degrees>PhD, FRCOphth</degrees><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Callahan</surname><given-names>Kelly</given-names></name><degrees>MPH</degrees><xref rid="aff6" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><name><surname>Weiss</surname><given-names>Helen A.</given-names></name><degrees>PhD</degrees><xref rid="aff1" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><name><surname>Burton</surname><given-names>Matthew J.</given-names></name><degrees>PhD, FRCOphth</degrees><xref rid="aff1" ref-type="aff">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>London School of Hygiene and Tropical Medicine, London, United Kingdom</aff><aff id="aff2"><label>2</label>The Carter Center, Addis Ababa, Ethiopia</aff><aff id="aff3"><label>3</label>Amhara Regional Health Bureau, Bahirdar, Ethiopia</aff><aff id="aff4"><label>4</label>Bahirdar University, Bahirdar, Ethiopia</aff><aff id="aff5"><label>5</label>Felegehiwot Referral Hospital, Bahirdar, Ethiopia</aff><aff id="aff6"><label>6</label>The Carter Center, Atlanta, Georgia</aff><author-notes><corresp id="cor1"><label>&#x02217;</label>Correspondence: Esmael Habtamu, MSc, International Centre for Eye Health, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London WC1E 7HT, UK.International Centre for Eye HealthFaculty of Infectious and Tropical DiseasesLondon School of Hygiene and Tropical MedicineKeppel StreetLondonWC1E 7HTUK <email>Esmael.Ali@lshtm.ac.uk</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>1</day><month>8</month><year>2017</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="ppub">.--><pub-date pub-type="ppub"><month>8</month><year>2017</year></pub-date><volume>124</volume><issue>8</issue><fpage>1143</fpage><lpage>1155</lpage><history><date date-type="received"><day>22</day><month>1</month><year>2017</year></date><date date-type="rev-recd"><day>7</day><month>3</month><year>2017</year></date><date date-type="accepted"><day>8</day><month>3</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; 2017 by the American Academy of Ophthalmology. All rights reserved.</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>American Academy of Ophthalmology</copyright-holder><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract id="abs0010"><sec><title>Purpose</title><p>Unfavorable outcomes after trachomatous trichiasis (TT) surgery are undermining the global trachoma elimination effort. This analysis investigates predictors of postoperative TT (PTT), eyelid contour abnormalities (ECAs), and granuloma in the 2 most common TT surgery procedures: posterior lamellar tarsal rotation (PLTR) and bilamellar tarsal rotation (BLTR).</p></sec><sec><title>Design</title><p>Secondary data analysis from a randomized, controlled, single-masked clinical trial.</p></sec><sec><title>Participants</title><p>A total of 1000 patients with TT, with lashes touching the eye or evidence of epilation, in association with tarsal conjunctival scarring.</p></sec><sec><title>Methods</title><p>Participants were randomly allocated and received BLTR (n&#x000a0;= 501) or PLTR (n&#x000a0;= 499) surgery. Disease severity at baseline, surgical incisions, sutures, and corrections were graded during and immediately after surgery. Participants were examined at 6 and 12 months by assessors masked to allocation.</p></sec><sec><title>Main Outcome Measures</title><p>Predictors of PTT, ECA, and granuloma.</p></sec><sec><title>Results</title><p>Data were available for 992 (99.2%) trial participants (496 in each arm). There was strong evidence that performing more peripheral dissection with scissors in PLTR (odd ratio [OR], 0.70; 95% confidence interval [CI], 0.54&#x02013;0.91; <italic>P</italic>&#x000a0;= 0.008) and BLTR (OR, 0.83; 95% CI, 0.72&#x02013;0.96; <italic>P</italic>&#x000a0;= 0.01) independently protected against PTT. Baseline major trichiasis and mixed location lashes and immediate postoperative central undercorrection independently predicted PTT in both surgical procedures. Peripheral lashes in PLTR (OR, 5.91; 95% CI, 1.48&#x02013;23.5; <italic>P</italic>&#x000a0;= 0.01) and external central incision height &#x02265;4 mm in BLTR (OR, 2.89; 95% CI, 1.55&#x02013;5.41; <italic>P</italic>&#x000a0;=&#x000a0;0.001) were independently associated with PTT. Suture interval asymmetry of &#x0003e;2 mm (OR, 3.18; 95% CI, 1.31&#x02013;7.70; <italic>P</italic>&#x000a0;= 0.01) in PLTR and baseline conjunctival scarring in BLTR (OR, 1.72; 95% CI, 1.06&#x02013;2.81; <italic>P</italic>&#x000a0;= 0.03) were independently associated with ECA. Older age was independently associated with ECA in both PLTR (<italic>P</italic>&#x000a0;value for trend &#x0003c; 0.0001) and BLTR (<italic>P</italic> value for trend&#x000a0;= 0.03). There was substantial intersurgeon variability in ECA rates for both PLTR (range, 19.0%&#x02013;36.2%) and BLTR (range, 6.1%&#x02013;28.7%) procedures. In PLTR surgery, irregular posterior lamellar incision at the center of the eyelid (OR, 6.72; 95% CI, 1.55&#x02013;29.04; <italic>P</italic>&#x000a0;= 0.01) and ECA (OR, 3.08; 95% CI, 1.37&#x02013;6.94; <italic>P</italic>&#x000a0;= 0.007) resulted in granuloma formation.</p></sec><sec><title>Conclusions</title><p>Poor postoperative outcomes in TT surgery were associated with inadequate peripheral dissection, irregular incision, asymmetric suture position and tension, inadequate correction, and lash location. Addressing these will improve TT surgical outcomes.</p></sec></abstract><kwd-group id="kwrds0010"><title>Abbreviations and Acronyms</title><kwd>BLTR, bilamellar tarsal rotation</kwd><kwd>CI, confidence interval</kwd><kwd>ECA, eyelid contour abnormality</kwd><kwd>FPC, follicles papillae cicatricae</kwd><kwd>OR, odds ratio</kwd><kwd>PLTR, posterior lamellar tarsal rotation</kwd><kwd>PTT, postoperative trachomatous trichiasis</kwd><kwd>RRR, relative risk ratio</kwd><kwd>TT, trachomatous trichiasis</kwd><kwd>WHO, World Health Organization</kwd></kwd-group></article-meta><notes><p id="misc0010">Manuscript no. 2017-170.</p></notes></front><body><p>Visual impairment from trachoma results from the in-turning of eyelashes that scar the cornea (trachomatous trichiasis [TT]). It remains the leading infectious cause of blindness worldwide.<xref rid="bib1" ref-type="bibr">1</xref>, <xref rid="bib2" ref-type="bibr">2</xref> Trachomatous trichiasis is a consequence of progressive conjunctival scarring caused by recurrent infection with <italic>Chlamydia trachomatis</italic>. It causes painful corneal abrasion, introduces infection, and alters the ocular surface, eventually leading to irreversible blindness from corneal opacification. Approximately 3.2 million people have untreated TT, and 2.4 million people are visually impaired from trachoma worldwide, of whom an estimated 1.2 million are irreversibly blind.<xref rid="bib3" ref-type="bibr">3</xref>, <xref rid="bib4" ref-type="bibr">4</xref></p><p>The World Health Organization (WHO) recommends corrective eyelid surgery to reduce the risk of visual impairment from TT.<xref rid="bib5" ref-type="bibr"><sup>5</sup></xref> The surgery involves an incision through the eyelid parallel to and a few millimeters above the lid margin. The terminal portion of the lid is externally rotated and sutured in the corrected position.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> In trachoma endemic countries, surgery usually is performed by nonphysician health workers.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> There is currently a major global effort to scale up surgical services to clear the current trichiasis backlog by 2020, with more than 200&#x02009;000 surgeries being performed annually.<xref rid="bib7" ref-type="bibr"><sup>7</sup></xref></p><p>However, unfavorable outcomes after TT surgery are undermining these efforts.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> Reported rates of postoperative TT (PTT) vary considerably, although 20% recurrence at 1 year is typical.<xref rid="bib9" ref-type="bibr">9</xref>, <xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib15" ref-type="bibr">15</xref> Moreover, a report from the Global Trachoma Mapping Project suggests the number of cases with unfavorable outcomes, including PTT, have increased significantly with increasing surgical output.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> Other adverse outcomes, such as eyelid contour abnormalities (ECAs) and granuloma after surgery, which occurs in 5% to 30% of cases, may have negative social and psychologic impact and deter other patients from accepting trichiasis surgery.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib16" ref-type="bibr">16</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib18" ref-type="bibr">18</xref>, <xref rid="bib19" ref-type="bibr">19</xref></p><p>Several clinical trials have reported unfavorable outcomes to be associated with surgical quality, type of surgical procedure, and preoperative disease severity.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref> The PTT rates between surgeons have been reported to range from 0% to 80%.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib13" ref-type="bibr">13</xref>, <xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib20" ref-type="bibr">20</xref> Management of unfavorable surgical outcomes is often challenging.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> First, it requires additional programmatic resources and specialized surgical skills.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> Second, the management of postoperative trichiasis is more challenging and probably has poorer outcomes than a primary procedure.<xref rid="bib8" ref-type="bibr"><sup>8</sup></xref> Therefore, every effort must be made to avoid unfavorable outcomes at the primary operation.</p><p>We have recently reported the outcome of a randomized controlled trial comparing the bilamellar tarsal rotation (BLTR) and the posterior lamellar tarsal rotation (PLTR) operations.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> The PLTR had a substantially lower risk of postoperative trichiasis and was more effective in severe TT cases than BLTR, although BLTR surgery had a lower&#x000a0;risk of granuloma formation. The preoperative, intraoperative, and postoperative factors that lead to unfavorable outcomes after TT surgery need to be studied and understood. From the data collected in this trial, we performed a secondary analysis to investigate factors that are associated with unfavorable outcomes (PTT, ECA, and granuloma) after BLTR and PLTR surgery, and identify potential approaches to minimize them.</p><sec id="sec1"><title>Methods</title><sec id="sec1.1"><title>Ethics Statement</title><p>This study was approved by the Ethiopian National Health Research Ethics Review Committee, London School of Hygiene and Tropical Medicine Ethics Committee, and Emory University Institutional Review Board. Written informed consent in Amharic was obtained from participants before enrollment. If a participant was unable to read and write, the information sheet and consent form were read to them and their consent was recorded by thumbprint. An independent Data and Safety Monitoring Committee oversaw the trial. The trial was conducted in compliance with the Declaration of Helsinki and International Conference on Harmonisation&#x02013;Good Clinical Practice. The trial is registered with the Pan African Clinical Trials Registry (<ext-link ext-link-type="uri" xlink:href="http://www.pactr.org" id="intref0010">http://www.pactr.org</ext-link>; PACTR201401000743135).</p></sec><sec id="sec1.2"><title>Study Design and Participants</title><p>This was a single-masked, individual-randomized, controlled trial conducted in Ethiopia. The trial methodology has been reported in detail.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Briefly, we recruited 1000 people with TT, with 1 or more lashes touching the eye or evidence of epilation in association with tarsal conjunctival scarring. People with trichiasis due to other causes, recurrent trichiasis after previous surgery, uncontrolled hypertension, pregnancy, and age &#x0003c;18 years were excluded. Recruitment was done through community-based screening in 3&#x000a0;districts of West Gojam Zone, Amhara Region, Ethiopia, between February and May 2014. We trained and standardized 6&#x000a0;trichiasis surgeons in both the PLTR and BLTR surgeries. We used the WHO TT surgery training and certification manual.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Participants were randomized to PLTR or BLTR (using the Waddell clamp) surgery, in a 1:1 allocation ratio for each surgeon. In both surgical procedures, 4/0 silk sutures with 3/8th circle, 19-mm cutting needles were used.</p></sec><sec id="sec1.3"><title>Clinical Assessments</title><p>At baseline, eyes were examined and graded using the Detailed WHO Follicles Papillae Cicatricae (FPC) Grading System.<xref rid="bib21" ref-type="bibr"><sup>21</sup></xref> Lashes touching the eye were counted and subdivided by the part of the eye contacted/location: cornea, lateral, or medial. Trichiasis subtypes were recorded as metaplastic, misdirected, or entropic.<xref rid="bib22" ref-type="bibr"><sup>22</sup></xref> Three trained nurses made intraoperative and immediate postoperative observations. The incision length was measured using a silk suture thread, which was measured against a ruler. The incision height was measured between the incision and the eyelid margin with a sterile ruler. In PLTR surgery, this was measured from the cut edge of the posterior lamella to the lid margin, whereas in BLTR the measurement was done externally on the skin incision. The incision was examined to determine regularity and whether it ran parallel to the lid margin. The scissor cuts made to complete the incision medially and laterally were counted. Data on the number, symmetry, and tension of the sutures were collected. Suture tension was considered &#x0201c;regular&#x0201d; if there was equal tension or firmness across all the sutures and &#x0201c;irregular&#x0201d; if at least 1 of the sutures was insufficiently tight or excessively tight compared with the others. The spacing between sutures was considered &#x0201c;symmetrical&#x0201d; if the difference in space between the central and medial sutures, and the central and lateral sutures was &#x02264;2 mm and &#x0201c;asymmetrical&#x0201d; if this difference was &#x0003e;2 mm. The degree of entropion correction was graded using a previously described system.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Two (primary gaze and up gaze) high-resolution digital photographs of the operated eye were taken before placing the dressing.</p><p>Participants were reexamined at 10 days, 6 months, and 12&#x000a0;months postoperatively. At 10 days, PTT, degree of lid eversion, infection, and granulomata were documented before suture removal. At 6 and 12 months, participants were reexamined after the same procedures as for baseline. Eyelid contour abnormalities were graded according to the PRET trial method.<xref rid="bib23" ref-type="bibr"><sup>23</sup></xref> Presenting distance vision was measured at baseline and 12 months using PeekAcuity software on a Smartphone in a dark room.<xref rid="bib24" ref-type="bibr"><sup>24</sup></xref> Three standardized high-resolution digital photographs of trichiasis, cornea, and tarsal conjunctiva were taken, using a Nikon (Tokyo, Japan) D90 digital SLR camera with 105-mm macro lens and R1C1 flash units at baseline and 6- and 12-month follow-ups.<xref rid="bib25" ref-type="bibr"><sup>25</sup></xref></p></sec><sec id="sec1.4"><title>Statistical Analysis</title><p>The sample size was determined on the basis of assumptions described in the primary article of this trial.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Data were double-entered into Access (Microsoft, Redmond, WA) and transferred to Stata 11 (StataCorp LP, College Station, TX) for analysis. For participants who received bilateral surgery, we randomly designated 1 eye to be the study eye for the analysis. The 3 main unfavorable TT surgical outcome measures used in this study are PTT, ECA, and granuloma. Predictors of PTT were defined as 1 or more lashes touching the eye, clinical evidence of epilation, or a history of repeat trichiasis surgery by 12 months. Factors associated with ECA were considered for any type and severity of ECA. In further stratified analysis, moderate and severe ECA were grouped together as &#x0201c;clinically significant&#x0201d; to identify what factors predict these, whereas mild ECA was considered &#x0201c;clinically nonsignificant.&#x0201d; A granuloma was defined as a fleshy tissue growth of at least 2 mm on the tarsal conjunctiva or at the edge of the eyelid. The analysis of ECA was based on the participants seen at 12 months, whereas the analysis of PTT and granuloma included all participants seen at least once during the 6- and 12-month follow-ups.</p><p>On the basis of severity, TT cases were categorized into minor trichiasis with &#x0003c;6 lashes or evidence of epilation in less than one-third of the lid margin, and major trichiasis with &#x02265;6 lashes or evidence of epilation in one-third or more of the lid margin. To analyze the association between trichiasis severity and corneal opacity, the detailed corneal opacity grading was converted into the WHO grading system. Mixed postoperative lash location by 12&#x000a0;months were defined as lashes touching more than 1 location at the 6-month or 12-month follow-up or during both follow-ups. The same definition was used for mixed postoperative lash types by 12&#x000a0;months.</p><p>Univariable and multivariable association of factors with major trichiasis at baseline, PTT by 12 months, ECA at 12 months, and granuloma by 12 months, and all binary outcomes were analyzed using logistic regression to estimate the odds ratio (OR) and 95% confidence interval (CI) for both surgical procedures separately. Likelihood ratio test was used to decide on the variables that should be included in the final multivariable logistic regression model. <italic>P</italic> value for trend was calculated for ordered categoric exposure variables, such as papillary grade, tarsal conjunctival scar, corneal opacity, visual acuity, and age. Categoric secondary outcomes (e.g., level of correction and ECA severity) were analyzed using multinomial logistic regression to estimate relative risk ratio (RRR) and 95% CI. Correlations between preoperative and postoperative trichiasis lashes location were analyzed using the Fisher exact test because of small observations.</p></sec></sec><sec id="sec2"><title>Results</title><sec id="sec2.1"><title>Participant Flow</title><p>The participant flow for this trial has been described in detail.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> In summary, 98% of the participants were examined at all 3 follow-up time points. At 12 months, 491 participants (98.4%) and 490 participants (97.8%) from the PLTR and BLTR arms were reassessed, respectively. The PTT data were available for 992&#x000a0;participants (99.2%), 496 in each arm, who were reassessed on at least 1 occasion during the 12-month period.</p></sec><sec id="sec2.2"><title>Demographic and Baseline Clinical Characteristics</title><p>Baseline demographic and clinical characteristics were analyzed for the 992 trial participants who were seen at 1 or more follow-ups. The majority of the participants were female (758, 76.4%), and the mean age was 47.0 (standard deviation, 14.7) years. Baseline clinical characteristics were balanced between the 2&#x000a0;surgical procedures (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>). Major trichiasis was present in 46.4% (230/496) and 48.2% (239/496) of the PLTR and BLTR cases, respectively. Most cases had moderate or severe entropion: PLTR (394/496, 79.4%) and BLTR (406/496, 81.8%). Most&#x000a0;individuals in both PLTR (381/496, 76.8%) and BLTR (374/496, 75.4%) groups had lashes in contact with the cornea. Metaplastic lashes were common: PLTR: 223/496 (45.0%), and BLTR: 205/496 (41.3%) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).<table-wrap id="tbl1" position="float"><label>Table&#x000a0;1</label><caption><p>Clinical and Demographic Characteristics of Cases Seen at Baseline and at 12 Months</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Characteristic</th><th colspan="2">Baseline<hr/></th><th colspan="2">By 12 Months<hr/></th></tr><tr><th>PLTR<hr/></th><th>BLTR<hr/></th><th>PLTR<hr/></th><th>BLTR<hr/></th></tr><tr><th>n/496 (%)</th><th>n/496 (%)</th><th>n/496 (%)</th><th>n/496 (%)</th></tr></thead><tbody><tr><td>Sex, female</td><td align="char">385 (77.6%)</td><td align="char">373 (75.2%)</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Age in yrs, mean (SD)</td><td align="char">47.0 (15.0)</td><td align="char">47.5 (14.9)</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>Entropion grade<xref rid="tbl1fnlowast" ref-type="table-fn">&#x02217;</xref></td><td/><td/><td/><td/></tr><tr><td>&#x000a0;None/mild (grade 0 and 1)</td><td align="char">102 (20.6%)</td><td align="char">90 (18.1%)</td><td align="char">484 (98&#x000b7;6%)</td><td align="char">485 (99.0%)</td></tr><tr><td>&#x000a0;Moderate (grade 2)</td><td align="char">314 (63.3%)</td><td align="char">331 (66.7%)</td><td align="char">6 (1.2)</td><td align="char">5 (1.0%)</td></tr><tr><td>&#x000a0;Severe (grade 3 and 4)</td><td align="char">80 (16.1%)</td><td align="char">75 (15.1%)</td><td align="char">1 (0.2)</td><td align="char">0 (0.0%)</td></tr><tr><td>Trichiasis severity</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;No trichiasis</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">433 (87.3)</td><td align="char">386 (77.8%)</td></tr><tr><td>&#x000a0;Minor trichiasis</td><td align="char">266 (53.6%)</td><td align="char">257 (51.8%)</td><td align="char">56 (11.3)</td><td align="char">97 (19.6%)</td></tr><tr><td>&#x000a0;Major trichiasis</td><td align="char">230 (46.4%)</td><td align="char">239 (48.2%)</td><td align="char">7 (1.41)</td><td align="char">13 (2.6%)</td></tr><tr><td>Lash location</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;No trichiasis</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">433 (87.3%)</td><td align="char">386 (77.8%)</td></tr><tr><td>&#x000a0;Epilating</td><td align="char">38 (7.7%)</td><td align="char">42 (8.5%)</td><td align="char">7 (1.4%)</td><td align="char">21 (4.2%)</td></tr><tr><td>&#x000a0;Corneal only</td><td align="char">381 (76.8%)</td><td align="char">374 (75.4%)</td><td align="char">32 (6.5%)</td><td align="char">55 (11.1%)</td></tr><tr><td>&#x000a0;Medial only</td><td align="char">3 (0.6%)</td><td align="char">0 (0.0%)</td><td align="char">12 (2.4%)</td><td align="char">7 (1.4%)</td></tr><tr><td>&#x000a0;Lateral only</td><td align="char">8 (1.6%)</td><td align="char">5 (1.0%)</td><td align="char">5 (1.0%)</td><td align="char">5 (1.0%)</td></tr><tr><td>&#x000a0;Corneal&#x000a0;+ Peripheral</td><td align="char">66 (13.3%)</td><td align="char">75 (15.1%)</td><td align="char">7 (1.4%)</td><td align="char">22 (4.4%)</td></tr><tr><td>Lash type</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;No trichiasis</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">433 (87.3%)</td><td align="char">386 (77.8%)</td></tr><tr><td>&#x000a0;Epilating</td><td align="char">38 (7.7%)</td><td align="char">42 (8.5%)</td><td align="char">7 (1.4%)</td><td align="char">21 (4.2%)</td></tr><tr><td>&#x000a0;Entropic only</td><td align="char">126 (25.4%)</td><td align="char">117 (23.4%)</td><td align="char">5 (1.0%)</td><td align="char">8 (1.6%)</td></tr><tr><td>&#x000a0;Metaplastic only</td><td align="char">223 (45.0%)</td><td align="char">205 (41.3%)</td><td align="char">37 (7.5%)</td><td align="char">66 (13.3%)</td></tr><tr><td>&#x000a0;Misdirected only</td><td align="char">9 (1.8%)</td><td align="char">13 (2.6%)</td><td align="char">2 (0.4%)</td><td align="char">4 (0.8%)</td></tr><tr><td>&#x000a0;Mixed</td><td align="char">100 (20.2%)</td><td align="char">119 (23.4%)</td><td align="char">12 (2.4%)</td><td align="char">11 (2.2%)</td></tr><tr><td>ECA<xref rid="tbl1fnlowast" ref-type="table-fn">&#x02217;</xref></td><td/><td/><td/><td/></tr><tr><td>&#x000a0;None</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">371 (75.6%)</td><td align="char">404 (82.4%)</td></tr><tr><td>&#x000a0;Clinically insignificant</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">89 (18.1%)</td><td align="char">49 (10.0%)</td></tr><tr><td>&#x000a0;Clinically significant</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">31 (6.3%)</td><td align="char">37 (7.6%)</td></tr><tr><td>Granuloma</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">26 (5.2%)</td><td align="char">11 (2.2%)</td></tr></tbody></table><table-wrap-foot><fn><p>BLTR&#x000a0;= bilamellar tarsal rotation; ECA&#x000a0;= eyelid contour abnormality; PLTR&#x000a0;= posterior lamellar tarsal rotation; SD&#x000a0;= standard deviation.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl1fnlowast"><label>&#x02217;</label><p id="ntpara0050">Data analyzed from 12-month examination (PLTR, N&#x000a0;= 491; BLTR, N&#x000a0;= 490).</p></fn></table-wrap-foot></table-wrap></p><p>Factors associated with preoperative TT severity in all cases are presented in <xref rid="appsec1" ref-type="sec">Table&#x000a0;S1</xref> (available at <ext-link ext-link-type="uri" xlink:href="http://www.aaojournal.org" id="intref0010a">www.aaojournal.org</ext-link>). In a multivariable analysis, major TT was significantly associated with being female, increasing corneal opacity, older age, increasing conjunctival scarring, and increasing conjunctival inflammation.</p></sec><sec id="sec2.3"><title>Postoperative Trachomatous Trichiasis</title><p>By 12 months, postoperative trichiasis was present in 173 of 992&#x000a0;cases (17.4%): PLTR 63/496 (12.7%), BLTR 110/496 (22.2%) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>). Most of the cases of PTT by 12 months were minor trichiasis (PLTR: 56/63, 80.9%; BLTR: 97/110, 88.2%). Metaplastic lashes were the most common type of PTT lashes&#x000a0;after both procedures: PLTR (37/63, 58.3%) and BLTR (66/110, 60.0%). The most common location of PTT in both PLTR (32/63, 50.8%) and BLTR (55/110, 50.0%) surgery was the cornea (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>).</p></sec><sec id="sec2.4"><title>Posterior Lamellar Tarsal Rotation Surgery</title><p>Univariable and multivariable analyses of factors associated with PTT by 12 months after PLTR surgery are presented in <xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>. In a multivariable analysis, there was strong evidence that performing more medial and lateral dissections using scissors to increase the length of surgical incision had a protective effect against PTT (OR, 0.70; 95% CI, 0.54&#x02013;0.91; <italic>P</italic>&#x000a0;= 0.008). The ECA at 12&#x000a0;months was associated with a lower rate of PTT (5.0% vs. 15.4%; OR, 0.24; 95% CI, 0.09&#x02013;0.60; <italic>P</italic>&#x000a0;= 0.002). However, there was evidence that PTT was independently associated with baseline major trichiasis (16.1% vs. 9.8%; OR, 1.97; 95% CI, 1.09&#x02013;3.56; <italic>P</italic>&#x000a0;=&#x000a0;0.03), peripheral lashes (36.4% vs. 10.0%; OR, 5.91; 95% CI, 1.48&#x02013;23.5; <italic>P</italic>&#x000a0;= 0.01), and mixed location lashes (22.8% vs. 10.0%; OR, 2.24; 95% CI, 1.09&#x02013;4.59; <italic>P</italic>&#x000a0;= 0.03) compared with corneal lashes and immediate postoperative central undercorrection compared with adequate correction (36.4% vs. 12.5%; OR, 4.97; 95% CI, 1.15&#x02013;21.5; <italic>P</italic>&#x000a0;= 0.03). Cases with irregular suture tension had a 2 times higher rate of PTT compared with those with regular suture tension (26.7% vs. 12.3%). However, this was not statistically significant (<italic>P</italic>&#x000a0;=&#x000a0;0.11). There was no evidence of association between PTT and surgeon (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>). Increased severity of baseline conjunctival scarring was significantly associated with major PTT by 12 months (mild, 0/4 [0.0%]; moderate, 4/51 [7.8%]; severe, 3/8 [37.5%]; OR, 7.40; 95% CI, 1.34&#x02013;40.8; <italic>P</italic> value for trend&#x000a0;= 0.02).<table-wrap id="tbl2" position="float"><label>Table&#x000a0;2</label><caption><p>Univariable and Multivariable Association of Factors with Postoperative Trichiasis by 1 Year after Posterior Lamellar Tarsal Rotation Surgery</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Demographic and Clinical Factors</th><th>PTT N&#x000a0;= 496<hr/></th><th colspan="2">Univariable Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th></tr><tr><th>n/N (%)</th><th>OR (95% CI)</th><th><italic>P</italic> Value</th><th>OR (95% CI)</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Age, yrs</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;18&#x02013;29</td><td align="char">3/59 (5.1%)</td><td align="char">1.18 (0.98&#x02013;1.41)</td><td align="char">0.08<xref rid="tbl2fnlowast" ref-type="table-fn">&#x02217;</xref></td><td align="char">1.23 (1.00&#x02013;1.50)</td><td align="char">0.05<xref rid="tbl2fnlowast" ref-type="table-fn">&#x02217;</xref></td></tr><tr><td>&#x000a0;30&#x02013;39</td><td align="char">8/85 (9.4%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;40&#x02013;49</td><td align="char">18/123 (14.6%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;50&#x02013;59</td><td align="char">17/108 (15.7%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;60&#x02013;69</td><td align="char">10/74 (13.5%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;70+</td><td align="char">7/47 (14.9%)</td><td/><td/><td/><td/></tr><tr><td>Trichiasis severity</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Minor</td><td align="char">26/266 (9.8%)</td><td align="char">1.77 (1.04&#x02013;3.03)</td><td align="char">0.04</td><td align="char">1.97 (1.09&#x02013;3.56)</td><td align="char">0.03</td></tr><tr><td>&#x000a0;Major</td><td align="char">37/230 (16.1%)</td><td/><td/><td/><td/></tr><tr><td>Lash location</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Epilating</td><td align="char">6/38 (15.8%)</td><td align="char">1.69 (0.66&#x02013;4.31)</td><td align="char">0.27</td><td align="char">1.72 (0.64&#x02013;4.62)</td><td align="char">0.29</td></tr><tr><td>&#x000a0;Corneal</td><td align="char">38/381 (10.0%)</td><td>1</td><td>&#x02013;</td><td>1</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Peripheral</td><td align="char">4/11 (36.4%)</td><td align="char">5.16 (1.44&#x02013;18.4)</td><td align="char">0.01</td><td align="char">5.91 (1.48&#x02013;23.5)</td><td align="char">0.01</td></tr><tr><td>&#x000a0;Corneal&#x000a0;+ Peripheral</td><td align="char">15/66 (22.7%)</td><td align="char">2.65 (1.36&#x02013;5.17)</td><td align="char">0.004</td><td align="char">2.24 (1.09&#x02013;4.59)</td><td align="char">0.03</td></tr><tr><td>Surgeon (relative to surgeon 4)</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;1</td><td align="char">8/89 (9.0%)</td><td align="char">0.81 (0.30&#x02013;2.16)</td><td align="char">0.67</td><td align="char">0.57 (0.20&#x02013;1.63)</td><td align="char">0.29</td></tr><tr><td>&#x000a0;2</td><td align="char">14/95 (14.7%)</td><td align="char">1.42 (0.60&#x02013;3.37)</td><td align="char">0.43</td><td align="char">1.40 (0.56&#x02013;3.50)</td><td align="char">0.48</td></tr><tr><td>&#x000a0;3</td><td align="char">12/84 (14.3%)</td><td align="char">1.37 (0.56&#x02013;3.35)</td><td align="char">0.49</td><td align="char">0.74 (0.27&#x02013;2.04)</td><td align="char">0.56</td></tr><tr><td>&#x000a0;4</td><td align="char">10/92 (10.9%)</td><td>1</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;5</td><td align="char">6/47 (12.8%)</td><td align="char">1.20 (0.41&#x02013;3.53)</td><td align="char">0.74</td><td align="char">1.62 (0.47&#x02013;5.55)</td><td align="char">0.45</td></tr><tr><td>&#x000a0;6</td><td align="char">13/89 (14.6%)</td><td align="char">1.40 (0.58&#x02013;3.39)</td><td align="char">0.45</td><td align="char">0.73 (0.27&#x02013;1.97)</td><td align="char">0.54</td></tr><tr><td>No. of medial and lateral dissections, median (range)</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;No recurrence</td><td align="char">1 (0&#x02013;26)</td><td align="char">0.78 (0.63&#x02013;0.96)</td><td align="char">0.02</td><td align="char">0.70 (0.54&#x02013;0.91)</td><td align="char">0.008</td></tr><tr><td>&#x000a0;Recurrence</td><td align="char">0 (0&#x02013;5)</td><td/><td/><td/><td/></tr><tr><td>Immediate postoperative central correction</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Corrected</td><td align="char">53/425 (12.5%)</td><td>1</td><td>&#x02013;</td><td>1</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Overcorrected</td><td align="char">6/60 (10.0%)</td><td align="char">0.78 (0.32&#x02013;1.90)</td><td align="char">0.58</td><td align="char">0.73 (0.28&#x02013;1.90)</td><td align="char">0.52</td></tr><tr><td>&#x000a0;Undercorrected</td><td align="char">4/11 (36.4%)</td><td align="char">4.01 (1.14&#x02013;14.2)</td><td align="char">0.03</td><td align="char">4.97 (1.15&#x02013;21.5)</td><td align="char">0.03</td></tr><tr><td>Suture tension across sutures</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Regular</td><td align="char">59/481 (12.3%)</td><td align="char">2.60 (0.80&#x02013;8.43)</td><td align="char">0.11</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Irregular</td><td align="char">4/15 (26.7%)</td><td/><td/><td/><td/></tr><tr><td>Surgical incision height in mm<xref rid="tbl2fnlowast" ref-type="table-fn">&#x02217;</xref></td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Central</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;&#x0003c;4 mm</td><td align="char">58/442 (13.1%)</td><td align="char">0.66 (0.26&#x02013;1.77)</td><td align="char">0.42</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;&#x02265;4 mm</td><td align="char">5/54 (9.3%)</td><td/><td/><td/><td/></tr><tr><td>ECA</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;No</td><td align="char">57/371 (15.4%)</td><td align="char">0.29 (0.12&#x02013;0.69)</td><td align="char">0.005</td><td align="char">0.24 (0.09&#x02013;0.60)</td><td align="char">0.002</td></tr><tr><td>&#x000a0;Yes</td><td align="char">6/120 (5.0%)</td><td/><td/><td/><td/></tr></tbody></table><table-wrap-foot><fn id="tspara0025"><p>CI&#x000a0;= confidence interval; ECA&#x000a0;= eyelid contour abnormality; OR&#x000a0;= odds ratio; PTT&#x000a0;= postoperative trachomatous trichiasis.</p></fn><fn id="tspara0030"><p>Analysis made using logistic regression. The following factors were tested and showed no association with PTT in a univariable analysis (<italic>P</italic> &#x0003e; 0.05) or were excluded from the multivariable analysis after a likelihood ratio test: gender, baseline entropion severity, trichiasis lash type at baseline, baseline conjunctival scarring severity, eye (right, left), number of mattress sutures, and height in millimeters. Age, surgeon, and preoperative trichiasis severity are known to be risk factors for PTT and are included in the multivariable model regardless of significance in a univariable analysis.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl2fnlowast"><label>&#x02217;</label><p id="ntpara0055"><italic>P</italic> value for trend.</p></fn></table-wrap-foot></table-wrap></p><p>There was no evidence of a significant association between surgical incision height of &#x02265;4 mm from the lid margin and PTT, although it tended to give a slightly lower rate of PTT&#x000a0;compared&#x000a0;with &#x0003c;4 mm incision height (9% vs. 13%) (<xref rid="tbl2" ref-type="table">Table&#x000a0;2</xref>). Incision height of &#x0003c;4&#x000a0;mm was not associated with undercorrection. However, a surgical incision height of &#x02265;4 mm was associated with immediate postoperative overcorrection at the corresponding site than a surgical incision height of &#x0003c;4 mm in PLTR surgery: central (27.3% [15/55] vs. 10.1% [45/444]; RRR=3.32; 95% CI,&#x000a0;1.70&#x02013;6.50; <italic>P</italic>&#x000a0;= 0.0004) and lateral (15.6% [7/45] vs. 5.3% [24/454]; RRR, 3.10; 95% CI, 1.25&#x02013;7.67; <italic>P</italic>&#x000a0;=&#x000a0;0.01). Among those with immediate postoperative central overcorrection, 94.9% (56/59) normalized at the 12-month follow-up.</p></sec><sec id="sec2.5"><title>Bilamellar Tarsal Rotation Surgery</title><p>Univariable and multivariable analyses of factors associated with PTT by 12 months in BLTR surgery are presented in <xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>. In a multivariable analysis, there was strong evidence that performing more medial and lateral dissections using scissors to increase the length of surgical incision had a protective effect on PTT (OR,&#x000a0;0.83; 95% CI, 0.72&#x02013;0.95; <italic>P</italic>&#x000a0;= 0.007). Older age (<italic>P</italic> value for trend&#x000a0;= 0.007), baseline major trichiasis (31.0% vs. 14.0%; OR, 1.86; 95% CI, 1.12&#x02013;3.10; <italic>P</italic>&#x000a0;= 0.02), mixed location lashes compared with corneal only lashes (46.7% vs. 16.8%; OR, 4.62; 95% CI, 2.51&#x02013;8.48; <italic>P</italic> &#x0003c; 0.0001), and immediate postoperative central undercorrection compared with adequate correction (60.0% vs. 22.6%; OR, 5.34; 95% CI, 1.32&#x02013;21.5; <italic>P</italic>&#x000a0;= 0.02) were independently associated with PTT (<xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>). Age &#x02265;60 years (OR,&#x000a0;2.05; 95% CI, 1.29&#x02013;3.25; <italic>P</italic>&#x000a0;= 0.002) and major TT at baseline (OR, 2.77; 95% CI, 1.76&#x02013;4.34; <italic>P</italic> &#x0003c; 0.0001) were independently associated with major PTT by 12 months after BLTR surgery.<table-wrap id="tbl3" position="float"><label>Table&#x000a0;3</label><caption><p>Univariable and Multivariable Association of Factors with Postoperative Trichiasis by 1 Year after Bilamellar Tarsal Rotation&#x000a0;Surgery</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">Demographic and Clinical Factors</th><th>PTT N&#x000a0;= 496<hr/></th><th colspan="2">Univariable Analysis<hr/></th><th colspan="2">Multivariable Analysis<hr/></th></tr><tr><th>n/N (%)</th><th>OR 95% CI</th><th><italic>P</italic> Value</th><th>OR 95% CI</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Age, yrs, median (IQR)</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;18&#x02013;29</td><td align="char">10/48 (20.8%)</td><td align="char">1.26 (1.09&#x02013;1.46)</td><td align="char">0.0005<xref rid="tbl3fndagger" ref-type="table-fn">&#x02020;</xref></td><td align="char">1.25 (1.06&#x02013;1.48)</td><td align="char">0.007<xref rid="tbl3fndagger" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td>&#x000a0;30&#x02013;39</td><td align="char">16/106 (15.1%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;40&#x02013;49</td><td align="char">17/107 (15.9%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;50&#x02013;59</td><td align="char">25/103 (24.3%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;60&#x02013;69</td><td align="char">24/82 (29.3%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;70+</td><td align="char">18/50 (36.0%)</td><td/><td/><td/><td/></tr><tr><td>Trichiasis severity</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Minor</td><td align="char">36/257 (14.0%)</td><td align="char">2.75 (1.76&#x02013;4.30)</td><td align="char">&#x0003c;0.0001</td><td align="char">1.86 (1.12&#x02013;3.10)</td><td align="char">0.02</td></tr><tr><td>&#x000a0;Major</td><td align="char">74/239 (31.0%)</td><td/><td/><td/><td/></tr><tr><td>Lash location</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Epilating</td><td align="char">10/42 (23.8%)</td><td align="char">1.54 (0.72&#x02013;3.30)</td><td align="char">0.26</td><td align="char">1.65 (0.73&#x02013;3.76)</td><td align="char">0.23</td></tr><tr><td>&#x000a0;Corneal</td><td align="char">63/374 (16.8%)</td><td>1</td><td>&#x02013;</td><td>1</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Peripheral</td><td align="char">2/5 (40.0%)</td><td align="char">3.29 (0.54&#x02013;20.1)</td><td align="char">0.20</td><td align="char">4.09 (0.60&#x02013;27.7)</td><td align="char">0.15</td></tr><tr><td>&#x000a0;Corneal&#x000a0;+ Peripheral</td><td align="char">35/75 (46.7%)</td><td align="char">4.32 (2.55&#x02013;7.33)</td><td align="char">&#x0003c;0.0001</td><td align="char">4.62 (2.51&#x02013;8.48)</td><td align="char">&#x0003c;0.0001</td></tr><tr><td>Conjunctival scarring, baseline</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;1</td><td align="char">8/54 (14.8%)</td><td align="char">1.65 (1.09&#x02013;2.52)</td><td align="char">0.02<xref rid="tbl3fndagger" ref-type="table-fn">&#x02020;</xref></td><td align="char">1.62 (0.99&#x02013;2.68)</td><td align="char">0.07<xref rid="tbl3fndagger" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td>&#x000a0;2</td><td align="char">78/366 (21.3%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;3</td><td align="char">24/76 (31.6%)</td><td/><td/><td/><td/></tr><tr><td>Surgeon (relative to surgeon 4)</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;1</td><td align="char">27/91 (29.7%)</td><td align="char">1.84 (0.92&#x02013;3.67)</td><td align="char">0.09</td><td align="char">1.34 (0.61&#x02013;2.95)</td><td align="char">0.46</td></tr><tr><td>&#x000a0;2</td><td align="char">17/93 (18.3%)</td><td align="char">0.97 (0.46&#x02013;2.05)</td><td align="char">0.94</td><td align="char">0.86 (0.37&#x02013;1.99)</td><td align="char">0.73</td></tr><tr><td>&#x000a0;3</td><td align="char">17/85 (20.0%)</td><td align="char">1.09 (0.51&#x02013;2.30)</td><td align="char">0.82</td><td align="char">0.54 (0.22&#x02013;1.35)</td><td align="char">0.19</td></tr><tr><td>&#x000a0;4</td><td align="char">17/91 (18.7%)</td><td>1</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;5</td><td align="char">12/47 (25.5%)</td><td align="char">1.49 (0.64&#x02013;3.46)</td><td align="char">0.35</td><td align="char">2.32 (0.89&#x02013;6.05)</td><td align="char">0.09</td></tr><tr><td>&#x000a0;6</td><td align="char">20/89 (22.5%)</td><td align="char">1.26 (0.61&#x02013;2.61)</td><td align="char">0.53</td><td align="char">1.22 (0.53&#x02013;2.81)</td><td align="char">0.63</td></tr><tr><td>No. of medial and lateral dissections, median (range)<xref rid="tbl3fndagger" ref-type="table-fn">&#x02020;</xref></td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;No recurrence</td><td align="char">2 (0&#x02013;17)</td><td align="char">0.91 (0.82&#x02013;1.01)</td><td align="char">0.06</td><td align="char">0.83 (0.72&#x02013;0.95)</td><td align="char">0.007</td></tr><tr><td>&#x000a0;Recurrence</td><td align="char">1 (0&#x02013;11)</td><td/><td/><td/><td/></tr><tr><td>Immediate postoperative central correction</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Corrected</td><td align="char">96/424 (22.6%)</td><td>1</td><td>&#x02013;</td><td>1</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Overcorrected</td><td align="char">8/62 (12.9%)</td><td align="char">0.51 (0.23&#x02013;1.10)</td><td align="char">0.09</td><td align="char">0.41 (0.18&#x02013;0.97)</td><td align="char">0.04</td></tr><tr><td>&#x000a0;Undercorrected</td><td align="char">6/10 (60.0%)</td><td align="char">5.12 (1.42&#x02013;18.5)</td><td align="char">0.01</td><td align="char">5.34 (1.32&#x02013;21.5)</td><td align="char">0.02</td></tr><tr><td>Suture tension across sutures</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Regular</td><td align="char">105/481 (21.8%)</td><td align="char">1.79 (0.60&#x02013;5.35)</td><td align="char">0.30</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Irregular</td><td align="char">5/15 (33.3%)</td><td/><td/><td/><td/></tr><tr><td>External surgical incision height in mm<xref rid="tbl3fnlowast" ref-type="table-fn">&#x02217;</xref></td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Central</td><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;&#x0003c;4 mm</td><td align="char">78/411 (19.0%)</td><td align="char">2.58 (1.56&#x02013;4.26)</td><td align="char">0.0002</td><td align="char">2.79 (1.52&#x02013;5.13)</td><td align="char">0.001</td></tr><tr><td>&#x000a0;&#x02265;4 mm</td><td align="char">32/85 (37.6%)</td><td/><td/><td/><td/></tr></tbody></table><table-wrap-foot><fn id="tspara0040"><p>CI&#x000a0;= confidence interval; IQR&#x000a0;= interquartile range; OR&#x000a0;= odds ratio; PTT&#x000a0;= postoperative trachomatous trichiasis.</p></fn><fn id="tspara0045"><p>Analysis made using logistic regression. The following factors were tested and showed no association with PTT in a univariable analysis (<italic>P</italic> &#x0003e; 0.05) or were excluded from the multivariable analysis after a likelihood ratio test: gender, baseline entropion severity, trichiasis lash type at baseline, eye (right, left), number of mattress sutures, and ECA. Age, surgeon, and preoperative trichiasis severity are known to be risk factors for PTT; therefore, they are included in the multivariable model regardless of significance in a univariable analysis.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fnlowast"><label>&#x02217;</label><p id="ntpara0060">Surgical incision height in BLTR surgery was measured externally on the skin.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl3fndagger"><label>&#x02020;</label><p id="ntpara0065"><italic>P</italic> value for trend.</p></fn></table-wrap-foot></table-wrap></p><p>In a univariable analysis, lids with external surgical incision height of &#x02265;4 mm from the lid margin were more likely to have PTT compared with those with &#x0003c;4 mm external incision height (central 37.6% vs. 19.0%; medial, 33.3% vs. 19.5%; lateral, 32.1&#x000a0;vs. 19.4%). However, in a multivariable model, this association was only significant for the central external incision height (OR, 2.79; 95% CI, 1.52&#x02013;5.13; <italic>P</italic>&#x000a0;= 0.001) (<xref rid="tbl3" ref-type="table">Table&#x000a0;3</xref>). Incision height was not associated with undercorrection or overcorrection in BLTR (data not shown).</p></sec><sec id="sec2.6"><title>Postoperative Lash Location</title><p>We analyzed whether postoperative trichiasis tended to reoccur in the same sector of the eyelid as it was found preoperatively. Participants with baseline medial only, lateral only, and mixed lashes had a significantly higher rate of postoperative lashes in the same area only compared with those with no baseline lashes in these areas of the eyelid in PLTR: (1) medial (66.7% [2/3] vs. 2.3% [11/493]; Fisher exact test <italic>P</italic>&#x000a0;= 0.002); (2) lateral (25.0% [2/8] vs. 0.61% [3/488]; Fisher exact test <italic>P</italic>&#x000a0;= 0.002); and (3) mixed location lashes (4.6% [3/66] vs. 0.93% [4/430]; Fisher exact test <italic>P</italic>&#x000a0;=&#x000a0;0.05); and in BLTR, mixed location lashes (17.3% [13/75] vs. 2.1% [9/421]; Fisher exact test <italic>P</italic> &#x0003c; 0.001). <xref rid="fig1" ref-type="fig">Figure&#x000a0;1</xref> illustrates this association. However, such correlation was not seen between preoperative and postoperative corneal only lashes for both PLTR (6.8% [26/381] vs. 6.1% [7/115]; Fisher exact test <italic>P</italic>&#x000a0;=&#x000a0;1.0) and BLTR (11.0% [41/374] vs. 13.1% [16/122]; Fisher exact test <italic>P</italic>&#x000a0;= 0.52) procedures.<fig id="fig1"><label>Figure&#x000a0;1</label><caption><p>Immediate postoperative undercorrection. <bold>Left</bold>: Immediate postoperative pictures of patient with central undercorrection. <bold>Right</bold>: The 12-month follow-up pictures of the same eye showing postoperative trachomatous trichiasis (PTT) at the same area.</p></caption><graphic xlink:href="gr1"/></fig></p><p>The PTT location by 12 months significantly correlates to areas of immediate postoperative undercorrection (<xref rid="fig1" ref-type="fig">Fig 1</xref>). Participants with immediate postoperative central undercorrection had a significantly higher rate of central PTT by 12 months than those with immediate postoperative adequate central correction in both PLTR (36.6% [4/11] vs. 7.5% [32/425]; OR, 7.01; 95% CI, 1.95&#x02013;25.2; <italic>P</italic>&#x000a0;=&#x000a0;0.0029) and BLTR (60.0% [6/10] vs. 15.3% [65/424]; OR, 8.28; 95% CI, 2.27&#x02013;30.2; <italic>P</italic>&#x000a0;= 0.0013) surgeries. The medial and lateral analyses were not possible because of insufficient events.</p></sec><sec id="sec2.7"><title>Eyelid Contour Abnormalities</title><p>Eyelid contour abnormalities were present in 206 of 981 participants (21.0%) at 12 months: PLTR 120/491 (24.4%) and BLTR 86/490 (17.6%) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>). Univariable and multivariable analyses of factors associated with ECA in PLTR and BLTR surgery are presented in <xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>. Intersurgeon variability is an important factor for ECA in both PLTR (range, 19.0%&#x02013;36.2%) and BLTR (range, 6.1%&#x02013;28.7%) procedures (<xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>). In both procedures, old age predicted ECA. Between sutures, distance asymmetry of &#x0003e;2 mm (<xref rid="fig2" ref-type="fig">Fig 2</xref>) in PLTR (52.2% vs. 23.1%; OR, 3.18; 95% CI, 1.31&#x02013;7.70; <italic>P</italic>&#x000a0;= 0.003) and baseline conjunctival scarring in BLTR (<italic>P</italic> value for trend&#x000a0;= 0.03) were independently associated with ECA. The use of 4 mattress sutures in BLTR surgery halved the rate of ECA compared with 3 mattress sutures (9.5% vs. 19.1%; <italic>P</italic>&#x000a0;= 0.03). However, this was not significant in a multivariable analysis (<xref rid="tbl4" ref-type="table">Table&#x000a0;4</xref>). In a separate multivariable analysis on the predictors of clinically significant ECA in PLTR&#x000a0;surgery, cases aged &#x02265;60 years (12.1% [14/116] vs. 4.5% [17/375]; RRR, 3.91; 95% CI, 1.79&#x02013;8.56; <italic>P</italic>&#x000a0;= 0.0006) and operated by surgeon 5 (17.0% vs. &#x0003c;8%; RRR, 3.23; 95% CI, 1.01&#x02013;10.4; <italic>P</italic>&#x000a0;= 0.049) had a higher risk of developing clinically significant ECA than their counterparts.<fig id="fig2"><label>Figure&#x000a0;2</label><caption><p>Suture distance asymmetry resulting in eyelid contour abnormality (ECA). <bold>Left</bold>: Immediate postoperative pictures showing asymmetry between suture intervals. <bold>Right</bold>: The 12-month follow-up pictures of the same eye with ECA.</p></caption><graphic xlink:href="gr2"/></fig><table-wrap id="tbl4" position="float"><label>Table&#x000a0;4</label><caption><p>Univariable and Multivariable Association of Factors with Eyelid Contour Abnormality at 1 Year by Type of Surgery</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Demographic and Clinical Factors</th><th colspan="5">PLTR (N&#x000a0;= 491)<hr/></th><th colspan="5">BLTR (N&#x000a0;= 490)<hr/></th></tr><tr><th>ECA<hr/></th><th colspan="2">Univariable<hr/></th><th colspan="2">Multivariable<hr/></th><th>ECA<hr/></th><th colspan="2">Univariable<hr/></th><th colspan="2">Multivariable<hr/></th></tr><tr><th>n/N (%)</th><th>OR 95% CI</th><th><italic>P</italic> Value</th><th>OR 95% CI</th><th><italic>P</italic> Value</th><th>n/N (%)</th><th>OR 95% CI</th><th><italic>P</italic> Value</th><th>OR 95% CI</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Age (yrs), continuous</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;18&#x02013;29</td><td align="char">8/59 (13.6%)</td><td align="char">1.39 (1.20&#x02013;1.62)</td><td align="char">&#x0003c;0.0001<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td><td align="char">1.39 (1.20&#x02013;1.62)</td><td align="char">&#x0003c;0.0001<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td><td align="char">5/48 (10.4%)</td><td align="char">1.14 (0.98&#x02013;1.34)</td><td align="char">0.09<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td><td align="char">1.20 (1.02&#x02013;1.42)</td><td align="char">0.03<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td>&#x000a0;30&#x02013;39</td><td align="char">11/85 (12.9%)</td><td/><td/><td/><td/><td align="char">17/106 (16.0%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;40&#x02013;49</td><td align="char">27/123 (21.9%)</td><td/><td/><td/><td/><td align="char">18/106 (17.0%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;50&#x02013;59</td><td align="char">32/108 (29.6%)</td><td/><td/><td/><td/><td align="char">20/101 (19.8%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;60&#x02013;69</td><td align="char">25/73 (34.2%)</td><td/><td/><td/><td/><td align="char">14/81 (17.3%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;70+</td><td align="char">17/43 (39.5%)</td><td/><td/><td/><td/><td align="char">12/48 (25.0%)</td><td/><td/><td/><td/></tr><tr><td>Conjunctival scarring, baseline</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;1</td><td align="char">13/47 (27.7%)</td><td align="char">0.74 (0.48&#x02013;1.13)</td><td align="char">0.16<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td><td>&#x02013;</td><td>&#x02013;</td><td align="char">5/52 (9.6%)</td><td align="char">1.52 (0.96&#x02013;2.42)</td><td align="char">0.08<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td><td align="char">1.72 (1.06&#x02013;2.81)</td><td align="char">0.03<xref rid="tbl4fndagger" ref-type="table-fn">&#x02020;</xref></td></tr><tr><td>&#x000a0;2</td><td align="char">94/370 (25.4%)</td><td/><td/><td/><td/><td align="char">65/366 (17.7%)</td><td/><td/><td/><td/></tr><tr><td>&#x000a0;3</td><td align="char">13/74 (17.6%)</td><td/><td/><td/><td/><td align="char">16/72 (22.2%)</td><td/><td/><td/><td/></tr><tr><td>Surgeon (relative to surgeon 3)</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;1</td><td align="char">21/86 (24.4%)</td><td align="char">1.37 (0.66&#x02013;2.86)</td><td align="char">0.40</td><td align="char">1.13 (0.53&#x02013;2.44)</td><td align="char">0.74</td><td align="char">10/91 (11.0%)</td><td align="char">1.90 (0.62&#x02013;5.81)</td><td align="char">0.26</td><td align="char">1.87 (0.60&#x02013;5.81)</td><td align="char">0.28</td></tr><tr><td>&#x000a0;2</td><td align="char">27/95 (28.4%)</td><td align="char">1.69 (0.83&#x02013;3.41)</td><td align="char">0.14</td><td align="char">1.60 (0.78&#x02013;3.28)</td><td align="char">0.20</td><td align="char">25/92 (27.2%)</td><td align="char">5.75 (2.08&#x02013;15.9)</td><td align="char">0.0007</td><td align="char">5.84 (2.07&#x02013;16.4)</td><td align="char">0.0008</td></tr><tr><td>&#x000a0;3</td><td align="char">16/84 (19.0%)</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">5/82 (6.1%)</td><td>1</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;4</td><td align="char">19/90 (21.1%)</td><td align="char">1.14 (0.54&#x02013;2.39)</td><td align="char">0.73</td><td align="char">0.99 (0.46&#x02013;2.14)</td><td align="char">0.98</td><td align="char">11/91 (12.1%)</td><td align="char">2.12 (0.70&#x02013;6.38)</td><td align="char">0.18</td><td align="char">2.13 (0.70&#x02013;6.52)</td><td align="char">0.18</td></tr><tr><td>&#x000a0;5</td><td align="char">17/47 (36.2%)</td><td align="char">2.41 (1.08&#x02013;5.40)</td><td align="char">0.03</td><td align="char">2.39 (1.04&#x02013;5.49)</td><td align="char">0.04</td><td align="char">10/47 (21.3%)</td><td align="char">4.16 (1.33&#x02013;13.05)</td><td align="char">0.014</td><td align="char">4.40 (1.37&#x02013;14.2)</td><td align="char">0.01</td></tr><tr><td>&#x000a0;6</td><td align="char">20/89 (22.5%)</td><td align="char">1.23 (0.59&#x02013;2.58)</td><td align="char">0.58</td><td align="char">1.15 (0.54&#x02013;2.44)</td><td align="char">0.72</td><td align="char">25/87 (28.7%)</td><td align="char">6.21 (2.25&#x02013;17.2)</td><td align="char">0.0004</td><td align="char">5.81 (2.07&#x02013;16.3)</td><td align="char">0.0009</td></tr><tr><td>No. of mattress sutures</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;3 sutures</td><td align="char">103/396 (26.0%)</td><td align="char">0.65 (0.37&#x02013;1.16)</td><td align="char">0.15</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">74/388 (19.1%)</td><td align="char">0.44 (0.21&#x02013;0.92)</td><td align="char">0.030</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;4 sutures</td><td align="char">17/91 (18.7%)</td><td/><td/><td/><td/><td align="char">9/95 (9.5%)</td><td/><td/><td/><td/></tr><tr><td>Suture distance</td><td/><td/><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Symmetric</td><td align="char">108/468 (23.1%)</td><td align="char">3.64 (1.56&#x02013;8.47)</td><td align="char">0.0028</td><td align="char">3.18 (1.31&#x02013;7.70)</td><td align="char">0.01</td><td align="char">77/457 (16.8%)</td><td align="char">1.85 (0.83&#x02013;4.14)</td><td align="char">0.13</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Asymmetric<xref rid="tbl4fnlowast" ref-type="table-fn">&#x02217;</xref></td><td align="char">12/23 (52.2%)</td><td/><td/><td/><td/><td align="char">9/33 (27.3%)</td><td/><td/><td/><td/></tr></tbody></table><table-wrap-foot><fn id="tspara0055"><p>BLTR&#x000a0;= bilamellar tarsal rotation; CI&#x000a0;= confidence interval; ECA&#x000a0;= eyelid contour abnormality; OR&#x000a0;= odds ratio; PLTR&#x000a0;= posterior lamellar tarsal rotation.</p></fn><fn id="tspara0060"><p>Analysis made using logistic regression. The following factors were tested and showed no association with ECA in a univariable analysis (<italic>P</italic> &#x0003e; 0.05) or were excluded from the multivariable analysis after a likelihood ratio test: gender, baseline trichiasis severity, baseline conjunctival scarring severity, suture tension across sutures, and surgical incision height in millimeters. Surgeon and age were included in the multivariable analysis regardless of significance in univariable analysis because these are known to be associated with ECA from previous studies.</p></fn><fn id="tspara0065"><p>Dashed lines indicated that variables are excluded from the final model after likelihood ratio test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl4fnlowast"><label>&#x02217;</label><p id="ntpara0070">Space between &#x0003e;2 mm symmetry difference between each other.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl4fndagger"><label>&#x02020;</label><p id="ntpara0075"><italic>P</italic> value for trend.</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec2.8"><title>Granuloma</title><p>Granuloma was documented in 37 of 992 participants (3.7%) during the 12-month period: PLTR 26/496 (5.2%) and BLTR 11/496 (2.2%) (<xref rid="tbl1" ref-type="table">Table&#x000a0;1</xref>). The development of a granuloma after PLTR surgery was independently associated with (1) a posterior lamellar incision that was irregular or not parallel to the lid margin in the central one-third of the eyelid (OR, 6.72; 95% CI, 1.55&#x02013;29.04; <italic>P</italic>&#x000a0;= 0.01) and (2) ECA (OR, 3.08; 95% CI, 1.37&#x02013;6.94; <italic>P</italic>&#x000a0;= 0.007) (<xref rid="tbl5" ref-type="table">Table&#x000a0;5</xref>). There was a nonsignificant trend for cases with suture tension irregularity having a higher rate (3-fold) of granuloma compared with those with regular suture tension in both PLTR (5.0% vs. 13.3%) and BLTR (2.1% vs. 6.7%) procedures. Preoperative disease severity, age, and surgeon were not associated with granuloma in both surgeries. There were no significant associations with granuloma after BLTR (<xref rid="tbl5" ref-type="table">Table&#x000a0;5</xref>).<table-wrap id="tbl5" position="float"><label>Table&#x000a0;5</label><caption><p>Univariable and Multivariable Association of Factors with Granuloma in 1 Year, by Type of Surgery</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="3">Demographic and Clinical Factors</th><th colspan="5">PLTR (N&#x000a0;= 496)<hr/></th><th colspan="3">BLTR (N&#x000a0;= 496)<hr/></th></tr><tr><th>Granuloma<hr/></th><th colspan="2">Univariable<hr/></th><th colspan="2">Multivariable<hr/></th><th>Granuloma<hr/></th><th colspan="2">Univariable<hr/></th></tr><tr><th>n/N (%)</th><th>OR 95% CI</th><th><italic>P</italic> Value</th><th>OR 95% CI</th><th><italic>P</italic> Value</th><th>n/N (%)</th><th>OR 95% CI</th><th><italic>P</italic> Value</th></tr></thead><tbody><tr><td>Age, yrs, continuous</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;18&#x02013;29</td><td align="char">4/59 (6.8%)</td><td align="char">1.00 (0.76&#x02013;1.30)</td><td align="char">0.98<xref rid="tbl5fnlowast" ref-type="table-fn">&#x02217;</xref></td><td>&#x02013;</td><td>&#x02013;</td><td align="char">0/48 (0.0%)</td><td align="char">1.20 (0.79&#x02013;1.79)</td><td align="char">0.39<xref rid="tbl5fnlowast" ref-type="table-fn">&#x02217;</xref></td></tr><tr><td>&#x000a0;30&#x02013;39</td><td align="char">5/85 (5.9%)</td><td/><td/><td/><td/><td align="char">1/106 (0.9%)</td><td/><td/></tr><tr><td>&#x000a0;40&#x02013;49</td><td align="char">5/123 (4.1%)</td><td/><td/><td/><td/><td align="char">3/107 (2.8%)</td><td/><td/></tr><tr><td>&#x000a0;50&#x02013;59</td><td align="char">3/108 (2.8%)</td><td/><td/><td/><td/><td align="char">4/103 (3.9%)</td><td/><td/></tr><tr><td>&#x000a0;60&#x02013;69</td><td align="char">7/74 (9.5%)</td><td/><td/><td/><td/><td align="char">3/82 (3.7%)</td><td/><td/></tr><tr><td>&#x000a0;70+</td><td align="char">2/47 (4.3%)</td><td/><td/><td/><td/><td align="char">0/50 (0.0%)</td><td/><td/></tr><tr><td>Surgeon (relative to surgeon 3)</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;1</td><td align="char">5/89 (5.6%)</td><td align="char">1.82 (0.42&#x02013;7.87)</td><td align="char">0.42</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">2/91 (2.2%)</td><td align="char">1.90 (0.62&#x02013;5.81)</td><td align="char">0.26</td></tr><tr><td>&#x000a0;2</td><td align="char">3/95 (3.2%)</td><td>1</td><td>&#x02013;</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">1/93 (1.1%)</td><td>1</td><td>&#x02013;</td></tr><tr><td>&#x000a0;3</td><td align="char">9/84 (10.7%)</td><td align="char">3.68 (0.96&#x02013;14.1)</td><td align="char">0.42</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">3/85 (3.5%)</td><td align="char">3.37 (0.34&#x02013;33.0)</td><td align="char">0.30</td></tr><tr><td>&#x000a0;4</td><td align="char">3/92 (3.3%)</td><td align="char">1.03 (0.20&#x02013;5.26)</td><td align="char">0.97</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">2/91 (2.2%)</td><td align="char">2.07 (0.18&#x02013;23.2)</td><td align="char">0.56</td></tr><tr><td>&#x000a0;5</td><td align="char">2/47 (4.3%)</td><td align="char">1.36 (0.22&#x02013;8.45)</td><td align="char">0.74</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">1/47 (2.1%)</td><td align="char">2.00 (0.12&#x02013;32.7)</td><td align="char">0.63</td></tr><tr><td>&#x000a0;6</td><td align="char">4/89 (4.5%)</td><td align="char">1.44 (0.31&#x02013;6.34)</td><td align="char">0.64</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">2/89 (2.2%)</td><td align="char">2.11 (0.19&#x02013;23.7)</td><td align="char">0.54</td></tr><tr><td>Central incision in relation to lid margin</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Regular/parallel</td><td align="char">23/486 (4.7%)</td><td align="char">8.6 (2.1&#x02013;35.5)</td><td align="char">0.003</td><td align="char">6.72 (1.55&#x02013;29.0)</td><td align="char">0.01</td><td align="char">1/13 (7.7%)</td><td>&#x02013;</td><td>&#x02013;</td></tr><tr><td>&#x000a0;Irregular/unparalleled or slanted</td><td align="char">3/10 (30.0%)</td><td/><td/><td/><td/><td align="char">25/483 (5.2%)</td><td/><td/></tr><tr><td>Suture tension across sutures</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;Regular</td><td align="char">24/481 (5.0%)</td><td align="char">2.93 (0.62&#x02013;13.7)</td><td align="char">0.17</td><td>&#x02013;</td><td>&#x02013;</td><td align="char">10/481 (2.1%)</td><td align="char">3.36 (0.40&#x02013;28.1)</td><td align="char">0.26</td></tr><tr><td>&#x000a0;Irregular</td><td align="char">2/15 (13.3%)</td><td/><td/><td/><td/><td align="char">1/15 (6.7%)</td><td/><td/></tr><tr><td>ECA</td><td/><td/><td/><td/><td/><td/><td/><td/></tr><tr><td>&#x000a0;No</td><td align="char">13/371 (3.5%)</td><td align="char">3.35 (1.51&#x02013;7.43)</td><td align="char">0.003</td><td align="char">3.08 (1.37&#x02013;6.94)</td><td align="char">0.007</td><td align="char">8/404 (2.0%)</td><td align="char">1.79 (.46&#x02013;6.89)</td><td align="char">0.40</td></tr><tr><td>&#x000a0;Yes</td><td align="char">13/120 (10.8%)</td><td/><td/><td/><td/><td align="char">3/86 (3.5%)</td><td/><td/></tr></tbody></table><table-wrap-foot><fn id="tspara0075"><p>BLTR&#x000a0;= bilamellar tarsal rotation; CI&#x000a0;= confidence interval; ECA&#x000a0;= eyelid contour abnormality; OR&#x000a0;= odds ratio; PLTR&#x000a0;= posterior lamellar tarsal rotation.</p></fn><fn id="tspara0080"><p>Analysis made using logistic regression. The following factors were tested and showed no association with granuloma in a univariable analysis (<italic>P</italic> &#x0003e; 0.05) or were excluded from the multivariable analysis after a likelihood ratio test: gender, baseline trichiasis severity, suture distance asymmetry, and surgical incision height in millimeters. Multivariable analysis for BLTR surgery is not presented because none of the tested factors showed significant association in univariable analysis.</p></fn><fn id="tspara0085"><p>Dashed lines indicated that variables are excluded from the final model after likelihood ratio test.</p></fn></table-wrap-foot><table-wrap-foot><fn id="tbl5fnlowast"><label>&#x02217;</label><p id="ntpara0080"><italic>P</italic> value for trend.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="sec3"><title>Discussion</title><p>Poor outcomes from TT surgery affect both the individual and the trachoma control program as a whole. A good understanding of the factors that increase the likelihood of an adverse outcome is crucial for surgeons, surgical trainers, and program planners. In this study, we explored factors associated with postoperative trichiasis, ECA, and granuloma formation after PLTR and BLTR surgeries. The results showed a range of intraoperative and immediate postoperative factors&#x000a0;are probably vital in shaping trichiasis surgery outcomes.</p><sec id="sec3.1"><title>Postoperative Trachomatous Trichiasis</title><sec id="sec3.1.1"><title>Peripheral Dissections</title><p>Perhaps one of the most useful findings of this study was that extending the length of the incision medially and laterally markedly reduced the rate of PTT for both PLTR and BLTR. A longer incision allows the distal segment to rotate adequately, and once secured with sutures, it is less likely to revert to the original entropic position. In addition, the longer incision probably allows the most medial and lateral extents of the lid to rotate more freely, thereby successfully correcting peripheral trichiasis.</p><p>Baseline lash location was an important determinant of PTT for both procedures. Peripheral TT lashes and mixed location lashes were substantially more likely to recur than corneal only lashes in PLTR surgery, whereas mixed location lashes were more likely to recur than corneal only lashes in BLTR surgery. This may be due to an insufficiently long surgical incision, failing to correct the trichiasis at the peripheries of the eyelid. An earlier study has reported comparable results, in which eyelids with shorter incisions had a 4-fold higher rate of recurrent TT than those with longer incision length.<xref rid="bib26" ref-type="bibr"><sup>26</sup></xref> Surgical training must emphasize the importance of the peripheral incision and dissection achieving adequate rotation.</p></sec><sec id="sec3.1.2"><title>Incision Height</title><p>There was a trend toward lower recurrence rate in cases with an incision height of &#x02265;4 mm from the lid margin in PLTR surgery. A higher incision height creates a larger distal segment that rotates more freely, pulling the lashes further away from the globe. In contrast, BLTR surgery cases with a central incision height of &#x02265;4 mm had approximately 2 times more PTT than those with&#x000a0;&#x0003c;4-mm incision height. The differential result of incision height between PLTR and BLTR surgery concurs with a previous prospective cohort study that reported a 72% (275/380) success rate in patients with mild to moderate trachomatous cicatricial entropion operated using BLTR with an incision made at &#x0003e;3 mm distance from the lid margin (on the eyelid crease) and an 82% (410/500) success rate in patients with moderate to severe cicatricial entropion using PLTR with an incision made at approximately 2 mm from the grey line.<xref rid="bib27" ref-type="bibr"><sup>27</sup></xref> There are several possible explanations for this seemingly paradoxical finding. First, it is possible that irrespective of incision height, the distal fragment rotates less freely in BLTR than PLTR perhaps because the procedure does not incorporate dissection between the 2 lamellae. Without this dissection, there may still be too much tension holding the large distal segment or pulling it back to the entropic position. Second, in our study, the incision height in BLTR was measured from the skin immediately after the incision. However, this distance may not be accurate because of the distension of the skin by the local anesthetic; therefore, this might give a different measure of the incision height than the measure in the posterior lamella because the posterior lamella anatomy is not distorted by the local anesthetic injection. Third, higher incisions in BLTR may result in overcorrection. Therefore, the surgeons may deliberately under-tighten the everting sutures as per the WHO training manual, resulting in undercorrection as the postoperative swelling settles.<xref rid="bib6" ref-type="bibr"><sup>6</sup></xref> Overall, these results indicate that the current WHO-recommended surgical incision height of approximately 3 mm should be maintained for both PLTR and BLTR surgeries. For BLTR surgery, the height of the incision to be made should be marked before the infiltration of anesthesia.</p></sec><sec id="sec3.1.3"><title>Suture Tension</title><p>Irregular suture tension at the end of surgery was associated with a trend toward more PTT in both PLTR and BLTR surgeries. Suture tension is an essential part of entropion correction in TT surgery. Irregularly and loosely tied sutures will become apparent as the swelling settles and will fail to hold the distal portion of the eyelid in the desired position, resulting in undercorrection or PTT. There are no previous reports on the effect of suture tension on surgical outcomes. Our study supports the WHO trichiasis surgery training manual recommendation that all sutures should be &#x0201c;tightened firmly enough to produce a slight overcorrection,&#x0201d; although we would consider omitting the word &#x0201c;slight&#x0201d; particularly for more severe cases and adding the importance of the sutures being evenly spaced (discussed later).</p></sec><sec id="sec3.1.4"><title>Patient-Related Factors</title><p>Preoperative major trichiasis and older age were independent predictors of PTT for both surgical procedures in this and other clinical trials.<xref rid="bib10" ref-type="bibr">10</xref>, <xref rid="bib12" ref-type="bibr">12</xref>, <xref rid="bib14" ref-type="bibr">14</xref>, <xref rid="bib17" ref-type="bibr">17</xref>, <xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib28" ref-type="bibr">28</xref>, <xref rid="bib29" ref-type="bibr">29</xref>, <xref rid="bib30" ref-type="bibr">30</xref> These were also predictors for major PTT in BLTR (but not in PLTR) surgery in this study, suggesting that such cases probably should be treated with PLTR. This is consistent with the literature that cases with severe disease should be treated with surgical procedures concentrating on the posterior lamella to minimize failure because it would effectively correct severe entropion with 180<sup>&#x000b0;</sup> rotation to the distal tarso-conjunctiva.<xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref> However, BLTR was considered effective for relatively less severe cases.<xref rid="bib11" ref-type="bibr">11</xref>, <xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib31" ref-type="bibr">31</xref>, <xref rid="bib32" ref-type="bibr">32</xref>, <xref rid="bib33" ref-type="bibr">33</xref> Operating on severe trichiasis cases is more challenging because of severe tarsal conjunctival scarring and associated lid shortening.<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib28" ref-type="bibr">28</xref> Severe conjunctival scarring and old age may affect wound healing, resulting in the eyelid reverting to its entropic position.<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib28" ref-type="bibr">28</xref> Preoperative major trichiasis and older patients ideally should be treated by the most experienced surgeon available to minimize failure.</p></sec></sec><sec id="sec3.2"><title>Eyelid Contour Abnormality</title><p>An ECA is an undesirable outcome of TT surgery even if the TT has been corrected. It is cosmetically unsightly and probably uncomfortable because it will affect tear film distribution and deter others from undergoing TT surgery.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref> As the sutures are tightened in PLTR surgery, the larger superior posterior lamella portion is pulled toward and tucked under the smaller distal portion, which both assists with rotating the distal portion and prevents the sutures being in contact with the cornea. Unequal suture positioning probably creates unbalanced forces that tucks the proximal fragment to a variable degree, resulting in lid margin distortion.<xref rid="bib28" ref-type="bibr"><sup>28</sup></xref> Marking where the suture should be positioned before injecting local anesthesia should be practiced to avoid suture asymmetry. The use of 4&#x000a0;mattress sutures tended to reduce ECA, probably because there is less opportunity for uneven suture placement. Further studies are needed to establish the effect of 4 mattress sutures in TT surgery. The ECA rates for both PLTR and BLTR varied by surgeons. In our study, 2 surgeons had consistently higher rates of ECA for both procedures. This indicates that despite rigorous training and extensive experience, subtle differences in how the incisions are made and the sutures are positioned and tightened can result in ECA. In addition, the primary objective of TT surgery is to treat the TT. Therefore, trainings and standardizations often focus more on how to achieve effective outward rotation to avoid surgical failure and recurrence than on prevention of ECA. Eyelid contour abnormalities were more frequent in older people after PLTR and BLTR surgery in this study, possibly because older individuals already have more distorted eyelids from the more advanced tarsal scarring or because the older eyelid is more pliable and therefore more susceptible to irregular suture tensions and forces. Similar results have been reported in earlier studies that used BLTR.<xref rid="bib26" ref-type="bibr">26</xref>, <xref rid="bib28" ref-type="bibr">28</xref></p></sec><sec id="sec3.3"><title>Granuloma</title><p>Granuloma is more common in PLTR. This is consistent with findings in other studies.<xref rid="bib19" ref-type="bibr">19</xref>, <xref rid="bib27" ref-type="bibr">27</xref>, <xref rid="bib28" ref-type="bibr">28</xref> In this study, there was evidence that an irregular/slanted posterior lamellar incision in the central third of the eyelid increased the rate of granuloma formation by more than 6-fold in PLTR surgery. These cases probably have a larger posterior lamella defect that supports the mechanism of granuloma formation after PLTR surgery than we had previously hypothesized, with granulomas developing from the subepithelial tissue where there is a persistent defect, and perhaps representing over-exuberant healing responses to fill the defects.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> It also has been reported that a gap between the incised edge of the posterior lamella from inadequate suturing in PLTR surgery may lead to granuloma formation.<xref rid="bib34" ref-type="bibr"><sup>34</sup></xref> Granuloma was less likely after BLTR, presumably because the operation, which used the Waddell clamp, has less conjunctival manipulation and does not leave a significant conjunctival defect, unless there is irregular suture tension, in which case the risk of granuloma is higher.<xref rid="bib13" ref-type="bibr"><sup>13</sup></xref></p></sec><sec id="sec3.4"><title>Study Strengths and Limitations</title><p>This study has a high follow-up rate of large cohort of patients, providing good power to examine the determinants of the outcomes of both PLTR and BLTR surgery. The potential design limitations of such a surgical trial, such as the risk of unmasking during the operation, and in the follow-ups due to surgical scars have been discussed in detail.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> However, independent photograph grading analysis showed there was no evidence of systematic bias in the field grading.<xref rid="bib11" ref-type="bibr"><sup>11</sup></xref> Moreover, procedure unmasking is less likely to be an issue in this particular analysis because determinants of surgical outcome were analyzed within each surgical procedure. Another limitation is that the surgical incision in BLTR surgery was measured externally on the skin after the injection of the local anesthesia, which could be a more variable measure than the incision and scar height on the posterior lamella. The suture tension grading probably is less objective than other grading measures used in this study. It is possible that other unstudied factors in this trial, such as genetic predisposition, imbalance in the initial wound-healing process, and progression of conjunctival inflammation and scarring, could influence TT surgical outcomes. We cannot rule out the possibility that some of the associations occurred by chance because we evaluated multiple risk factors.</p><p>There is currently an unprecedented global effort to improve TT surgical quality and reduce the number of people developing PTT who would rejoin the TT backlog. The findings of this study contribute to trachoma-control programs by helping to identify modifiable operative factors that influence outcome. Improving outcomes probably will promote uptake and reduces the overall cost to the patients and program. The major surgical factors that are found to affect outcomes in this study are relatively straightforward to address during surgical training and surgical practice and should be incorporated into TT surgery programs. These should be included in the WHO surgeon standardization checklist as mandatory items for certification. Surgical outcome monitoring should be strengthened. A system for frequent and regular supportive supervision and active follow-up of patients should be implemented. Surgeons with consistently poor surgical outcomes should be identified and given additional practical training. Further research is needed on how to improve surgical outcomes, on the effect of immediate postoperative correction of an unfavorable outcome, and on how to manage PTT and clinically significant ECA.</p></sec></sec></body><back><ref-list id="cebib0010"><title>References</title><ref id="bib1"><label>1</label><element-citation publication-type="journal" id="sref1"><person-group person-group-type="author"><name><surname>Pascolini</surname><given-names>D.</given-names></name><name><surname>Mariotti</surname><given-names>S.P.</given-names></name></person-group><article-title>Global estimates of visual impairment: 2010</article-title><source>Br J Ophthalmol</source><volume>96</volume><year>2012</year><fpage>614</fpage><lpage>618</lpage><pub-id pub-id-type="pmid">22133988</pub-id></element-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sref2"><person-group person-group-type="author"><name><surname>Mariotti</surname><given-names>S.P.</given-names></name><name><surname>Pascolini</surname><given-names>D.</given-names></name><name><surname>Rose-Nussbaumer</surname><given-names>J.</given-names></name></person-group><article-title>Trachoma: global magnitude of a preventable cause of blindness</article-title><source>Br J Ophthalmol</source><volume>93</volume><year>2009</year><fpage>563</fpage><lpage>568</lpage><pub-id pub-id-type="pmid">19098034</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="book" id="sref3"><person-group person-group-type="author"><collab>WHO Alliance for the Global Elimination of Trachoma by 2020</collab></person-group><chapter-title>Eliminating Trachoma: Accelerating Towards 2020</chapter-title><year>2016</year></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sref4"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>Global WHO Alliance for the Elimination of Blinding Trachoma by 2020. Progress report on elimination of trachoma, 2010</article-title><source>Wkly Epidemiol Rec</source><volume>87</volume><year>2012</year><fpage>161</fpage><lpage>168</lpage><pub-id pub-id-type="pmid">22574352</pub-id></element-citation></ref><ref id="bib5"><label>5</label><element-citation publication-type="book" id="sref5"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><chapter-title>Trachoma Control: A Guide for Programme Managers</chapter-title><year>2006</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc></element-citation></ref><ref id="bib6"><label>6</label><element-citation publication-type="book" id="sref6"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><chapter-title>Trichiasis Surgery for Trachoma</chapter-title><year>2013</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc></element-citation></ref><ref id="bib7"><label>7</label><element-citation publication-type="journal" id="sref7"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group><article-title>WHO Alliance for the Global Elimination of Blinding Trachoma by the year 2020. Progress report on elimination of trachoma, 2013</article-title><source>Wkly Epidemiol Rec</source><volume>89</volume><year>2014</year><fpage>421</fpage><lpage>428</lpage><pub-id pub-id-type="pmid">25275153</pub-id></element-citation></ref><ref id="bib8"><label>8</label><mixed-citation publication-type="other" id="sref8">World Health Organization Alliance for the Global Elimination of Trachoma by 2020. Second Global Scientific Meeting on Trachomatous Trichiasis. Cape Town, South Africa, November 4&#x02013;6,&#x000a0;2015.</mixed-citation></ref><ref id="bib9"><label>9</label><element-citation publication-type="journal" id="sref9"><person-group person-group-type="author"><name><surname>Khandekar</surname><given-names>R.</given-names></name><name><surname>Mohammed</surname><given-names>A.J.</given-names></name><name><surname>Courtright</surname><given-names>P.</given-names></name></person-group><article-title>Recurrence of trichiasis: a long-term follow-up study in the Sultanate of Oman</article-title><source>Ophthalmic Epidemiol</source><volume>8</volume><year>2001</year><fpage>155</fpage><lpage>161</lpage><pub-id pub-id-type="pmid">11471085</pub-id></element-citation></ref><ref id="bib10"><label>10</label><element-citation publication-type="journal" id="sref10"><person-group person-group-type="author"><name><surname>Rajak</surname><given-names>S.N.</given-names></name><name><surname>Habtamu</surname><given-names>E.</given-names></name><name><surname>Weiss</surname><given-names>H.A.</given-names></name></person-group><article-title>Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: a randomised controlled trial</article-title><source>PLoS Med</source><volume>8</volume><year>2011</year><fpage>e1001137</fpage><pub-id pub-id-type="pmid">22180732</pub-id></element-citation></ref><ref id="bib11"><label>11</label><element-citation publication-type="journal" id="sref11"><person-group person-group-type="author"><name><surname>Habtamu</surname><given-names>E.</given-names></name><name><surname>Wondie</surname><given-names>T.</given-names></name><name><surname>Aweke</surname><given-names>S.</given-names></name></person-group><article-title>Posterior lamellar versus bilamellar tarsal rotation surgery for trachomatous trichiasis in Ethiopia: a randomised controlled trial</article-title><source>Lancet Glob Health</source><volume>4</volume><year>2016</year><fpage>e175</fpage><lpage>e184</lpage><pub-id pub-id-type="pmid">26774708</pub-id></element-citation></ref><ref id="bib12"><label>12</label><element-citation publication-type="journal" id="sref12"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>M.J.</given-names></name><name><surname>Kinteh</surname><given-names>F.</given-names></name><name><surname>Jallow</surname><given-names>O.</given-names></name></person-group><article-title>A&#x000a0;randomised controlled&#x000a0;trial of azithromycin following surgery for trachomatous trichiasis in the Gambia</article-title><source>Br J Ophthalmol</source><volume>89</volume><year>2005</year><fpage>1282</fpage><lpage>1288</lpage><pub-id pub-id-type="pmid">16170117</pub-id></element-citation></ref><ref id="bib13"><label>13</label><element-citation publication-type="journal" id="sref13"><person-group person-group-type="author"><name><surname>Gower</surname><given-names>E.W.</given-names></name><name><surname>West</surname><given-names>S.K.</given-names></name><name><surname>Harding</surname><given-names>J.C.</given-names></name></person-group><article-title>Trachomatous trichiasis clamp vs. standard bilamellar tarsal rotation instrumentation for trichiasis surgery: results of a randomized clinical trial</article-title><source>JAMA Ophthalmol</source><volume>131</volume><year>2013</year><fpage>294</fpage><lpage>301</lpage><pub-id pub-id-type="pmid">23494035</pub-id></element-citation></ref><ref id="bib14"><label>14</label><element-citation publication-type="journal" id="sref14"><person-group person-group-type="author"><name><surname>West</surname><given-names>S.K.</given-names></name><name><surname>West</surname><given-names>E.S.</given-names></name><name><surname>Alemayehu</surname><given-names>W.</given-names></name></person-group><article-title>Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia</article-title><source>Arch Ophthalmol</source><volume>124</volume><year>2006</year><fpage>309</fpage><lpage>314</lpage><pub-id pub-id-type="pmid">16534049</pub-id></element-citation></ref><ref id="bib15"><label>15</label><element-citation publication-type="journal" id="sref15"><person-group person-group-type="author"><name><surname>Reacher</surname><given-names>M.</given-names></name><name><surname>Huber</surname><given-names>M.</given-names></name><name><surname>Canagaratnam</surname><given-names>R.</given-names></name><name><surname>Alghassany</surname><given-names>A.</given-names></name></person-group><article-title>A&#x000a0;trial of surgery for trichiasis of the upper lid from trachoma</article-title><source>Br J Ophthalmol</source><volume>74</volume><year>1990</year><fpage>109</fpage><lpage>113</lpage><pub-id pub-id-type="pmid">2178677</pub-id></element-citation></ref><ref id="bib16"><label>16</label><element-citation publication-type="journal" id="sref16"><person-group person-group-type="author"><name><surname>Habtamu</surname><given-names>E.</given-names></name><name><surname>Burton</surname><given-names>M.</given-names></name></person-group><article-title>Clearing the trichiasis backlog: experiences in Amhara, Ethiopia</article-title><source>Community Eye Health</source><volume>28</volume><year>2015</year><fpage>38</fpage><pub-id pub-id-type="pmid">26692652</pub-id></element-citation></ref><ref id="bib17"><label>17</label><element-citation publication-type="journal" id="sref17"><person-group person-group-type="author"><name><surname>Alemayehu</surname><given-names>W.</given-names></name><name><surname>Melese</surname><given-names>M.</given-names></name><name><surname>Bejiga</surname><given-names>A.</given-names></name></person-group><article-title>Surgery for trichiasis by ophthalmologists versus integrated eye care&#x000a0;workers: a randomized trial</article-title><source>Ophthalmology</source><volume>111</volume><year>2004</year><fpage>578</fpage><lpage>584</lpage><pub-id pub-id-type="pmid">15019339</pub-id></element-citation></ref><ref id="bib18"><label>18</label><element-citation publication-type="journal" id="sref18"><person-group person-group-type="author"><name><surname>Bog</surname><given-names>H.</given-names></name><name><surname>Yorston</surname><given-names>D.</given-names></name><name><surname>Foster</surname><given-names>A.</given-names></name></person-group><article-title>Results of community-based eyelid surgery for trichiasis due to trachoma</article-title><source>Br J Ophthalmol</source><volume>77</volume><year>1993</year><fpage>81</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">8435423</pub-id></element-citation></ref><ref id="bib19"><label>19</label><element-citation publication-type="journal" id="sref19"><person-group person-group-type="author"><name><surname>Dhaliwal</surname><given-names>U.</given-names></name><name><surname>Monga</surname><given-names>P.</given-names></name><name><surname>Gupta</surname><given-names>V.</given-names></name></person-group><article-title>Comparison of three surgical procedures of differing complexity in the correction of trachomatous upper lid entropion: a prospective study</article-title><source>Orbit</source><volume>23</volume><year>2004</year><fpage>227</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">15590524</pub-id></element-citation></ref><ref id="bib20"><label>20</label><element-citation publication-type="journal" id="sref20"><person-group person-group-type="author"><name><surname>Rajak</surname><given-names>S.N.</given-names></name><name><surname>Habtamu</surname><given-names>E.</given-names></name><name><surname>Weiss</surname><given-names>H.A.</given-names></name></person-group><article-title>Surgery versus epilation for the treatment of minor trichiasis in Ethiopia: a randomised controlled noninferiority trial</article-title><source>PLoS Med</source><volume>8</volume><year>2011</year><fpage>e1001136</fpage><pub-id pub-id-type="pmid">22180731</pub-id></element-citation></ref><ref id="bib21"><label>21</label><element-citation publication-type="book" id="sref21"><person-group person-group-type="author"><name><surname>Dawson</surname><given-names>C.R.</given-names></name><name><surname>Jones</surname><given-names>B.R.</given-names></name><name><surname>Tarizzo</surname><given-names>M.L.</given-names></name></person-group><chapter-title>Guide to Trachoma Control in Programmes for the Prevention of Blindness</chapter-title><year>1981</year><publisher-name>World Health Organization</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc></element-citation></ref><ref id="bib22"><label>22</label><element-citation publication-type="journal" id="sref22"><person-group person-group-type="author"><name><surname>Rajak</surname><given-names>S.N.</given-names></name><name><surname>Habtamu</surname><given-names>E.</given-names></name><name><surname>Weiss</surname><given-names>H.A.</given-names></name></person-group><article-title>The clinical phenotype of trachomatous trichiasis in Ethiopia: not all trichiasis is due to entropion</article-title><source>Invest Ophthalmol Vis Sci</source><volume>52</volume><year>2011</year><fpage>7974</fpage><lpage>7980</lpage><pub-id pub-id-type="pmid">21896855</pub-id></element-citation></ref><ref id="bib23"><label>23</label><element-citation publication-type="journal" id="sref23"><person-group person-group-type="author"><name><surname>Gower</surname><given-names>E.W.</given-names></name><name><surname>West</surname><given-names>S.K.</given-names></name><name><surname>Cassard</surname><given-names>S.D.</given-names></name></person-group><article-title>Definitions and standardization of a new grading scheme for eyelid contour abnormalities after trichiasis surgery</article-title><source>PLoS Negl Trop Dis</source><volume>6</volume><year>2012</year><fpage>e1713</fpage><pub-id pub-id-type="pmid">22745845</pub-id></element-citation></ref><ref id="bib24"><label>24</label><element-citation publication-type="journal" id="sref24"><person-group person-group-type="author"><name><surname>Bastawrous</surname><given-names>A.</given-names></name><name><surname>Rono</surname><given-names>H.K.</given-names></name><name><surname>Livingstone</surname><given-names>I.A.</given-names></name></person-group><article-title>Development and validation of a smartphone-based visual acuity test (peek&#x000a0;acuity) for clinical practice and community-based fieldwork</article-title><source>JAMA Ophthalmol</source><volume>133</volume><year>2015</year><fpage>930</fpage><lpage>937</lpage><pub-id pub-id-type="pmid">26022921</pub-id></element-citation></ref><ref id="bib25"><label>25</label><element-citation publication-type="journal" id="sref25"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>C.H.</given-names></name><name><surname>Mtuy</surname><given-names>T.</given-names></name><name><surname>Derrick</surname><given-names>T.</given-names></name></person-group><article-title>Eyescores: an open platform for secure electronic data and photographic evidence collection in ophthalmological field studies</article-title><source>Br J Ophthalmol</source><volume>97</volume><year>2013</year><fpage>671</fpage><lpage>672</lpage><pub-id pub-id-type="pmid">23264546</pub-id></element-citation></ref><ref id="bib26"><label>26</label><element-citation publication-type="journal" id="sref26"><person-group person-group-type="author"><name><surname>Gower</surname><given-names>E.W.</given-names></name><name><surname>Merbs</surname><given-names>S.L.</given-names></name><name><surname>Munoz</surname><given-names>B.E.</given-names></name></person-group><article-title>Rates and risk factors for unfavorable outcomes 6 weeks after trichiasis surgery</article-title><source>Invest Ophthalmol Vis Sci</source><volume>52</volume><year>2011</year><fpage>2704</fpage><lpage>2711</lpage><pub-id pub-id-type="pmid">21051704</pub-id></element-citation></ref><ref id="bib27"><label>27</label><element-citation publication-type="journal" id="sref27"><person-group person-group-type="author"><name><surname>Nasr</surname><given-names>A.M.</given-names></name></person-group><article-title>Eyelid complications in trachoma. I. Cicatricial entropion</article-title><source>Ophthalmic Surg</source><volume>20</volume><year>1989</year><fpage>800</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">2616128</pub-id></element-citation></ref><ref id="bib28"><label>28</label><element-citation publication-type="journal" id="sref28"><person-group person-group-type="author"><name><surname>Rajak</surname><given-names>S.N.</given-names></name><name><surname>Habtamu</surname><given-names>E.</given-names></name><name><surname>Weiss</surname><given-names>H.A.</given-names></name></person-group><article-title>The outcome of trachomatous trichiasis surgery in Ethiopia: risk factors for recurrence</article-title><source>PLoS Negl Trop Dis</source><volume>7</volume><year>2013</year><fpage>e2392</fpage><pub-id pub-id-type="pmid">23991241</pub-id></element-citation></ref><ref id="bib29"><label>29</label><element-citation publication-type="journal" id="sref29"><person-group person-group-type="author"><name><surname>Burton</surname><given-names>M.J.</given-names></name><name><surname>Bowman</surname><given-names>R.J.C.</given-names></name><name><surname>Faal</surname><given-names>H.</given-names></name></person-group><article-title>Long term outcome of trichiasis surgery in the Gambia</article-title><source>Br J Ophthalmol</source><volume>89</volume><year>2005</year><fpage>575</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">15834088</pub-id></element-citation></ref><ref id="bib30"><label>30</label><element-citation publication-type="journal" id="sref30"><person-group person-group-type="author"><name><surname>Merbs</surname><given-names>S.L.</given-names></name><name><surname>Oktavec</surname><given-names>K.C.</given-names></name><name><surname>Munoz</surname><given-names>B.E.</given-names></name></person-group><article-title>Lower postoperative scar height is associated with increased postoperative trichiasis 1 year after bilamellar tarsal rotation surgery</article-title><source>Ophthalmic Epidemiol</source><volume>22</volume><year>2015</year><fpage>200</fpage><lpage>207</lpage><pub-id pub-id-type="pmid">26158578</pub-id></element-citation></ref><ref id="bib31"><label>31</label><element-citation publication-type="journal" id="sref31"><person-group person-group-type="author"><name><surname>Kemp</surname><given-names>E.G.</given-names></name><name><surname>Collin</surname><given-names>J.R.</given-names></name></person-group><article-title>Surgical management of upper lid entropion</article-title><source>Br J Ophthalmol</source><volume>70</volume><year>1986</year><fpage>575</fpage><lpage>579</lpage><pub-id pub-id-type="pmid">3741821</pub-id></element-citation></ref><ref id="bib32"><label>32</label><element-citation publication-type="journal" id="sref32"><person-group person-group-type="author"><name><surname>Waddell</surname><given-names>K.</given-names></name></person-group><article-title>A&#x000a0;new clamp for bilamellar tarsal rotation for trachomatous trichiasis</article-title><source>Community Eye Health</source><volume>22</volume><year>2009</year><fpage>13</fpage><pub-id pub-id-type="pmid">19506716</pub-id></element-citation></ref><ref id="bib33"><label>33</label><element-citation publication-type="journal" id="sref33"><person-group person-group-type="author"><name><surname>Kettesy</surname><given-names>A.</given-names></name></person-group><article-title>On genesis and operation of the cicatricial (trachomatous) entropion of the upper lid</article-title><source>Br J Ophthalmol</source><volume>32</volume><year>1948</year><fpage>419</fpage><lpage>423</lpage><pub-id pub-id-type="pmid">18170470</pub-id></element-citation></ref><ref id="bib34"><label>34</label><element-citation publication-type="journal" id="sref34"><person-group person-group-type="author"><name><surname>Graham</surname><given-names>P.J.</given-names></name></person-group><article-title>An operation for entropion and trichiasis: a composite of methods for lid margin rotation</article-title><source>Aust J Opthalmol</source><volume>10</volume><year>1982</year><fpage>267</fpage><lpage>270</lpage></element-citation></ref></ref-list><sec id="appsec1" sec-type="supplementary-material"><title>Supplementary Data</title><p><supplementary-material content-type="local-data" id="ec1"><caption><title>Table&#x000a0;S1</title></caption><media xlink:href="mmc1.pdf"/></supplementary-material></p></sec><ack id="ack0010"><title>Acknowledgments</title><p>The authors thank the trial Data and Safety Monitoring Board members for their service and valuable input into the trial: Dr. Wondu Alemayehu, Dr. Deborah Watson-Jones, Dr. Alemayehu Sisay, Dr. Michael Dejene, and Dr. Demisse Tadesse; the trachoma control program in Amhara National Regional State of Ethiopia, which is in collaboration with the Regional Health Bureau and the Lions-Carter Center SightFirst Initiative; the research study team; the study participants; West Gojam Zone Health Office, the Woreda Health Offices, and Mecha Woreda Administration Office.</p></ack><fn-group><fn id="d31e2484"><p id="ntpara0010a">Supplemental material available at <ext-link ext-link-type="uri" xlink:href="http://www.aaojournal.org" id="intref0015">www.aaojournal.org</ext-link>.</p></fn><fn id="d31e2490"><p id="ntpara0010">Financial Disclosure(s): The author(s) have no proprietary or commercial interest in any materials discussed in this article.</p></fn><fn id="d31e2493"><p id="ntpara0015">Supported by the Wellcome Trust through a Senior Research Fellowship to M.J.B. (grant no. 098481/Z/12/Z).</p></fn><fn id="d31e2496"><p id="ntpara0020">Author Contributions:</p></fn><fn id="d31e2499"><p id="ntpara0025">Conception and design: Habtamu, Rajak, Callahan, Weiss, Burton</p></fn><fn id="d31e2502"><p id="ntpara0030">Analysis and interpretation: Habtamu, Rajak, Weiss, Burton</p></fn><fn id="d31e2505"><p id="ntpara0035">Data collection: Habtamu, Wondie, Aweke, Tadesse, Zerihun, Gashaw, Wondimagegn, Mengistie</p></fn><fn id="d31e2508"><p id="ntpara0040">Obtained funding: Burton</p></fn><fn id="d31e2511"><p id="ntpara0045">Overall responsibility: Burton</p></fn></fn-group></back></article>